Literature DB >> 8958985

Effects of hypertension and propranolol upon aneurysm expansion in the Anidjar/Dobrin aneurysm model.

M A Ricci1, J M Slaiby, G R Gadowski, E D Hendley, P Nichols, D B Pilcher.   

Abstract

Propranolol has been suggested to slow aortic aneurysm (AAA) expansion by a mechanism independent of simple blood pressure (BP) reduction. To investigate this hypothesis, we designed a series of experiments to examine the effects of hypertension and propranolol upon AAA expansion. Using an established animal model, we induced AAA in normotensive and genetically hypertensive rats by perfusion of the isolated infrarenal aorta with elastase for two hours. Systolic tail BP was monitored with a plethysmograph. AAA size was measured directly with a micrometer on postoperative days 7 and 14. All data are expressed as the mean +/- standard deviation (SD). BP (mmHg) was significantly higher in hypertensive rats: 164 +/- 15 versus 119 +/- 7 (p < 0.001). AAA were also significantly larger in hypertensive rats with a mean expansion rate (mm/day) nearly twice that of normotensive animals: 0.13 +/- 0.09 versus 0.07 +/- 0.03. In a second series of animals, propranolol treatment was compared to placebo. In those animals, hypertensive propranolol-treated rats had significantly smaller AAA than placebo-treated controls (p < 0.05). There was no difference in normotensive animals but these rats had an unexplained paradoxical rise in BP with treatment. In this model, hypertension increases the expansion rate of AAA. Propranolol reduced the size of AAA in hypertensive animals, at least in part because of a decrease in BP. Other possible mechanisms of propranolol's action may be operative and require further study.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8958985     DOI: 10.1111/j.1749-6632.1996.tb33301.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  4 in total

1.  The time course of elastin fiber degeneration in a rat aneurysm model.

Authors:  T Yamaguchi; M Yokokawa; M Suzuki; S Higashide; Y Katoh; S Sugiyama; T Misaki
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

2.  ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice.

Authors:  Lisa A Cassis; Manisha Gupte; Sarah Thayer; Xuan Zhang; Richard Charnigo; Deborah A Howatt; Debra L Rateri; Alan Daugherty
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-27       Impact factor: 4.733

3.  Experimental models of abdominal aortic aneurysms.

Authors:  Janice C Tsui
Journal:  Open Cardiovasc Med J       Date:  2010-11-26

Review 4.  Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm.

Authors:  Koichi Yoshimura; Noriyasu Morikage; Shizuka Nishino-Fujimoto; Akira Furutani; Bungo Shirasawa; Kimikazu Hamano
Journal:  Curr Drug Targets       Date:  2018       Impact factor: 3.465

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.